Literature DB >> 15032722

Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights.

M Cherry1, D H Williams.   

Abstract

Recent years have seen an explosion in the number of publicly available x-ray crystal structures of protein kinases. These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes. Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, molecular templates for ATP competitive inhibitors and alternative mechanisms of inhibition. The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity. In addition, protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition. The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15032722     DOI: 10.2174/0929867043455792

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  22 in total

1.  Crystallization and preliminary crystallographic analysis of hygromycin B phosphotransferase from Escherichia coli.

Authors:  Daisuke Iino; Yasuaki Takakura; Mika Kuroiwa; Ryouta Kawakami; Yasuyuki Sasaki; Takayuki Hoshino; Kanju Ohsawa; Akira Nakamura; Shunsuke Yajima
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-21

2.  Crystallization and preliminary crystallographic analysis of an aminoglycoside kinase from Legionella pneumophila.

Authors:  Christopher T Lemke; Jiyoung Hwang; Bing Xiong; Nicholas P Cianciotto; Albert M Berghuis
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-01

3.  Measuring and interpreting the selectivity of protein kinase inhibitors.

Authors:  Lynette A Smyth; Ian Collins
Journal:  J Chem Biol       Date:  2009-06-06

4.  New class of competitive inhibitor of bacterial histidine kinases.

Authors:  Raymond Gilmour; J Estelle Foster; Qin Sheng; Jonathan R McClain; Anna Riley; Pei-Ming Sun; Wai-Leung Ng; Dalai Yan; Thalia I Nicas; Kenneth Henry; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  Extraction and validation of substructure profiles for enriching compound libraries.

Authors:  Wee Kiang Yeo; Mei Lin Go; Shahul Nilar
Journal:  J Comput Aided Mol Des       Date:  2012-09-16       Impact factor: 3.686

6.  Protein kinase-inhibitor database: structural variability of and inhibitor interactions with the protein kinase P-loop.

Authors:  Ronak Y Patel; Robert J Doerksen
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

7.  Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth.

Authors:  Dan Zhu; Jennifer Hensel; Robert Hilgraf; Mahan Abbasian; Owen Pornillos; Gordafaried Deyanat-Yazdi; Xuequn Helen Hua; Sarah Cox
Journal:  Mol Cell Biochem       Date:  2009-07-21       Impact factor: 3.396

8.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

9.  Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations.

Authors:  Anshuman Dixit; Gennady M Verkhivker
Journal:  PLoS Comput Biol       Date:  2009-08-28       Impact factor: 4.475

10.  Drug design with Cdc7 kinase: a potential novel cancer therapy target.

Authors:  Masaaki Sawa; Hisao Masai
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.